PlainRecalls
FDA Drug Moderate Class II Terminated

GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-3745-21.

Reported: May 1, 2013 Initiated: April 19, 2013 #D-298-2013

Product Description

GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-3745-21.

Reason for Recall

Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.

Details

Recalling Firm
Qualitest Pharmaceuticals
Units Affected
10,373 bottles
Distribution
Nationwide
Location
Huntsville, AL

Frequently Asked Questions

What product was recalled?
GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-3745-21.. Recalled by Qualitest Pharmaceuticals. Units affected: 10,373 bottles.
Why was this product recalled?
Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 1, 2013. Severity: Moderate. Recall number: D-298-2013.